Hormone Therapy and Risk of Breast Cancer: Where Are We Now?

Several studies have examined the clinical benefits of hormone replacement therapy (HRT). However, because long-term use of HRT has been implicated as a risk factor for the development of breast cancer, some women remain skeptical when considering this therapy to address their vasomotor symptoms. He...

Descripción completa

Detalles Bibliográficos
Autores principales: Micha, John P., Rettenmaier, Mark A., Bohart, Randy D., Goldstein, Bram H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Menopause 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452594/
https://www.ncbi.nlm.nih.gov/pubmed/36070869
http://dx.doi.org/10.6118/jmm.21035
Descripción
Sumario:Several studies have examined the clinical benefits of hormone replacement therapy (HRT). However, because long-term use of HRT has been implicated as a risk factor for the development of breast cancer, some women remain skeptical when considering this therapy to address their vasomotor symptoms. Hence, physicians and nurses should actively engage in constructive discourse with their patients regarding HRT while specifically reviewing the potential risks of its extended use as well as provide the available medical alternatives the patients could potentially use.

Ejemplares similares